How should information in a universal registration document be updated before it is a constituent part of a prospectus? (Updated 09/09/2026)

How should the mark-to-market value of contracts for difference that are not cleared by a CCP be reported in accordance with Regulation (EU) No 648/2012 and standard 13 of the international financial reporting standards?

Since most of the (potential) applicants aim to settle the “cash leg” of transactions with or as a DLT-SS / DLT-TSS using e-money tokens the question arises if Article 12(1) b) CSDR regarding the relevant authorities is applicable (“the central banks in the Union issuing the most relevant currencies in which settlement takes place”).

If shares are offered to the public under shareholders’ agreement restricting the transferability of the shares, would this have an impact on the status of those shares as 'transferable securities'?

In the context of buy-back programmes under Article 5(1) of MAR, which transactions should be included in the average daily volume for the purpose of the calculation of the 25% limit foreseen in Article 3(3) of CDR 2016/1052? Should that include the total volume traded on-venue or should transactions executed under a pre-trade transparency waiver be excluded?